Table 3.
Bivariate analysis of liver transplant predictors
Variable |
Liver transplant |
P value | |
No | Yes | ||
Gender (Male), n (%) | 70 (42.9) | 93 (57.1) | 0.451 |
Age (yr), (mean, ± SD, range) | 58.1 ± 8.7 (27-77) | 57.9 ± 7.8 (32-73) | 0.8861 |
Child-Pugh score, n (%) | 0.644 | ||
A (5-6) | 43 (44.8) | 53 (55.2) | |
B (7-9) | 33 (40.7) | 48 (59.3) | |
C (10-15) | 7 (53.8) | 6 (46.2) | |
MELD, mean ± SD, range | 11 (6-28) | 12 (7-23) | 0.0552 |
AFP (ng/dL), (mean, ± SD, range) | 12.75 (0.6-22,411) | 8.8 (1.1-8,216) | 0.3352 |
Coagulopathy, n (%) | 0.001 | ||
No | 60 (55.0) | 49 (45.0) | |
Yes | 27 (30.7) | 61 (69.3) | |
Trombocytopenia, n (%) | 0.002 | ||
No | 42 (58.3) | 30 (41.7) | |
Yes | 45 (36.0) | 80 (64.0) | |
Group, n (%) | < 0.001 | ||
Downstaging | 41 (66.1) | 21 (33.9) | |
Bridging | 46 (34.1) | 89 (65.9) | |
Vascular lake phenomenon, n (%) | 0.776 | ||
No | 71 (44.7) | 88 (55.3) | |
Yes | 16 (42.1) | 22 (57.9) | |
Total | 87 (44.2) | 110 (55.8) |
Chi-squared test.
Student’s t test;
Mann-Whitney test. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma; MELD: Model for End-Stage Liver Disease.